Clinical Trials
46 trialsReduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
Virginia Commonwealth University
Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
Mayo Clinic
Palliative Thoracic ImmunoRT
University Health Network, Toronto
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
University of Oklahoma
ARTIA-Lung
Varian, a Siemens Healthineers Company
InDuRanS
University Hospital, Bonn
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
University of Washington
Electro-Acupuncture in Lung cancER : EALER Study
Guangzhou University of Traditional Chinese Medicine
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Alliance for Clinical Trials in Oncology
PACCELIO
TheraOp
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation
Massachusetts General Hospital
Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)
Stanford University
Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC
Shanghai Chest Hospital
PRIME-Lung
Trans Tasman Radiation Oncology Group
ARIS
Hopitaux Prives de Metz, Groupe UNEOS
Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
Zhejiang Cancer Hospital
Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
NMN
Sichuan University
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
West Virginia University
Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC
Peking University Cancer Hospital & Institute
AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer
IRCCS San Raffaele
Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
First People's Hospital of Hangzhou
NutriCim
Erasmus Medical Center
OPPRESS
Second Affiliated Hospital, School of Medicine, Zhejiang University
ICONIC
CNAO National Center of Oncological Hadrontherapy
HIBIC-NSCLC
The First People's Hospital of Neijiang
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
Tang-Du Hospital
Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations
Wake Forest University Health Sciences
Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy
Hunan Province Tumor Hospital
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer
The First Affiliated Hospital of Zhengzhou University
Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.
Prince of Songkla University
STARTNEWERA-OM
Radiotherapy Oncology Centre "Santa Maria" Hospital
I-STOP
University of Milano Bicocca
Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy
Zhejiang Cancer Hospital
CIETAI and Sequential Radiotherapy in Squamous Lung Cancer
Third Military Medical University
STICk-IM-NSCLC
Duke University
TRAILOCLORI01
Institut Cancerologie de l'Ouest
ctDNA as a Biomarker for Treatment in Advanced NSCLC
Fuzhou General Hospital
Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation
Shanghai Chest Hospital
Immunopheresis Alone or in Combination With Paclitaxel or Atezolizumab in Non-small Cell Lung Cancer (NSCLC).
Immunicom Inc
Neoadjuvant Immunotherapy in Advanced NSCLC
Power Life Sciences Inc.
Camrelizumab Combined With Local Treatment in NSCLC Patients With BM
Zhejiang Cancer Hospital
Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
H. Lee Moffitt Cancer Center and Research Institute
Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)
H. Lee Moffitt Cancer Center and Research Institute